Zhang Z, Zhang N, Ding S
Neurochem Res. 2025; 50(2):117.
PMID: 40085335
DOI: 10.1007/s11064-025-04370-6.
Wang X, Rong C, Leng W, Niu P, He Z, Wang G
Eur J Med Res. 2025; 30(1):148.
PMID: 40025562
PMC: 11874805.
DOI: 10.1186/s40001-025-02399-5.
McLaughlin R, Top I, Laguna A, Hernandez C, Katz H, Livi L
In Vitro Model. 2025; 2(1-2):25-41.
PMID: 39872876
PMC: 11756444.
DOI: 10.1007/s44164-023-00046-z.
Zhang L, Zhou Y, Yang Z, Jiang L, Yan X, Zhu W
J Neuroinflammation. 2025; 22(1):7.
PMID: 39806503
PMC: 11730833.
DOI: 10.1186/s12974-025-03334-5.
Zhao Y, Huang Y, Cao Y, Yang J
Biomolecules. 2024; 14(10).
PMID: 39456137
PMC: 11505625.
DOI: 10.3390/biom14101204.
Targeting the neurovascular unit: Therapeutic potential of traditional Chinese medicine for the treatment of stroke.
Wu B, Zhou D, Mei Z
Heliyon. 2024; 10(19):e38200.
PMID: 39386825
PMC: 11462356.
DOI: 10.1016/j.heliyon.2024.e38200.
Doxorubicin-induced neurotoxicity differently affects the hippocampal formation subregions in adult mice.
Dias-Carvalho A, Ferreira M, Reis-Mendes A, Ferreira R, Bastos M, Fernandes E
Heliyon. 2024; 10(11):e31608.
PMID: 38868005
PMC: 11168325.
DOI: 10.1016/j.heliyon.2024.e31608.
Biomaterial strategies for regulating the neuroinflammatory response.
Galindo A, Frey Rubio D, Hettiaratchi M
Mater Adv. 2024; 5(10):4025-4054.
PMID: 38774837
PMC: 11103561.
DOI: 10.1039/d3ma00736g.
Astrocyte KDM4A mediates chemokines and drives neutrophil infiltration to aggravate cerebral ischemia and reperfusion injury.
Huang J, Wang X, Gao T, Wang X, Yu M, Song H
J Cereb Blood Flow Metab. 2023; 44(4):491-507.
PMID: 38008899
PMC: 10981400.
DOI: 10.1177/0271678X231216158.
Targeting Neurogenesis in Seeking Novel Treatments for Ischemic Stroke.
Nagase T, Kin K, Yasuhara T
Biomedicines. 2023; 11(10).
PMID: 37893146
PMC: 10604112.
DOI: 10.3390/biomedicines11102773.
MRI tracking/detection of bone marrow mesenchymal stromal cells transplantation for treatment of ischemic cerebral infarction.
Zhao N, Niu R, Zhu Y, Yu C
Ibrain. 2023; 7(1):12-20.
PMID: 37786876
PMC: 10528978.
DOI: 10.1002/j.2769-2795.2021.tb00059.x.
The cell-specific roles of Nrf2 in acute and chronic phases of ischemic stroke.
Fadoul G, Ikonomovic M, Zhang F, Yang T
CNS Neurosci Ther. 2023; 30(3):e14462.
PMID: 37715557
PMC: 10916447.
DOI: 10.1111/cns.14462.
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
Vincenzi M, Kremic A, Jouve A, Lattanzi R, Miele R, Benharouga M
Pharmacol Rev. 2023; 75(6):1167-1199.
PMID: 37684054
PMC: 10595023.
DOI: 10.1124/pharmrev.122.000801.
Microglia-Astrocyte Interaction in Neural Development and Neural Pathogenesis.
Sun M, You H, Hu X, Luo Y, Zhang Z, Song Y
Cells. 2023; 12(15).
PMID: 37566021
PMC: 10417796.
DOI: 10.3390/cells12151942.
Tetramethylpyrazine promotes stroke recovery by inducing the restoration of neurovascular unit and transformation of A1/A2 reactive astrocytes.
Feng X, Li M, Lin Z, Li M, Lu Y, Zhuang Y
Front Cell Neurosci. 2023; 17:1125412.
PMID: 37051111
PMC: 10083399.
DOI: 10.3389/fncel.2023.1125412.
Neuroimmune mechanisms and therapies mediating post-ischaemic brain injury and repair.
Shichita T, Ooboshi H, Yoshimura A
Nat Rev Neurosci. 2023; 24(5):299-312.
PMID: 36973481
DOI: 10.1038/s41583-023-00690-0.
Clarifying the mechanism of apigenin against blood-brain barrier disruption in ischemic stroke using systems pharmacology.
Wang X, Yu Z, Dong F, Li J, Niu P, Ta Q
Mol Divers. 2023; 28(2):609-630.
PMID: 36949297
DOI: 10.1007/s11030-023-10607-9.
A steroid receptor coactivator small molecule "stimulator" attenuates post-stroke ischemic brain injury.
McClendon L, Garcia R, Lazaro T, Robledo A, Vasandani V, Evan Luna Z
Front Mol Neurosci. 2022; 15:1055295.
PMID: 36533127
PMC: 9751323.
DOI: 10.3389/fnmol.2022.1055295.
New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke.
Wei Z, Xie Y, Wei M, Zhao H, Ren K, Feng Q
Front Pharmacol. 2022; 13:1020918.
PMID: 36425577
PMC: 9679292.
DOI: 10.3389/fphar.2022.1020918.
Fragmentation of rest periods, astrocyte activation, and cognitive decline in older adults with and without Alzheimer's disease.
Wu R, Tripathy S, Menon V, Yu L, Buchman A, Bennett D
Alzheimers Dement. 2022; 19(5):1888-1900.
PMID: 36335579
PMC: 10697074.
DOI: 10.1002/alz.12817.